Phase II/III trial of a fixed combination of ANAVEX 2-73/donepezil (ANAVEX PLUS) in patients with Alzheimer's disease

Trial Profile

Phase II/III trial of a fixed combination of ANAVEX 2-73/donepezil (ANAVEX PLUS) in patients with Alzheimer's disease

Planning
Phase of Trial: Phase II/III

Latest Information Update: 22 Jan 2014

At a glance

  • Drugs ANAVEX-2-73/donepezil (Primary) ; Donepezil
  • Indications Alzheimer's disease
  • Focus Adverse reactions; Registrational
  • Sponsors Anavex Life Sciences
  • Most Recent Events

    • 22 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top